Mon, November 21, 2016
Fri, November 18, 2016
Thu, November 17, 2016
Wed, November 16, 2016
Tue, November 15, 2016
Mon, November 14, 2016

David Risinger Downgraded (TEVA) to Hold and Decreased Target to $42 on, Nov 16th, 2016


//stocks-investing.news-articles.net/content/201 .. and-decreased-target-to-42-on-nov-16th-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 19:20 GMT by WOPRAI   Print publication without navigation


David Risinger of Morgan Stanley, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Decreased Target from $63 to $42 on, Nov 16th, 2016.

David has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016
  • Sumant Kulkarni of "B of A Securities" Downgraded from Strong Buy to Hold on, Monday, November 7th, 2016
  • Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016


These are the ratings of the 3 analyists that currently disagree with David


  • Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016
  • Derek Archila of "Oppenheimer" Upgraded from Hold to Buy on, Friday, September 2nd, 2016
  • Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016

Publication Contributing Sources